Expert Review of Cardiovascular Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.What's the optimal duration of anticoagulation in patients with left ventricular thrombus?
Expert Rev Cardiovasc Ther. 2023 Oct 13. doi: 10.1080/14779072.2023.2270906. Online ahead of print.ABSTRACTINTRODUCTION: Left ventricular thrombus (LVT) occurs in acute myocardial infarction and in ischemic and non-ischemic cardiomyopathies. LVT may result in embolic stroke. Currently, the duration of anticoagulation for LVT is unclear. This is an important clinical question as prolonged anticoagulation is associated with increased bleeding risks, while premature discontinuation may result in embolic complications.AREAS COVERED: There are no randomized trial data regarding anticoagulation duration for LVT. Guidelines and e...
Source: Expert Review of Cardiovascular Therapy - October 13, 2023 Category: Cardiology Authors: Fang Qin Goh Ching-Hui Sia Mark Y Chan Leonard Ll Yeo Benjamin Yq Tan Source Type: research
Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)
Expert Rev Cardiovasc Ther. 2023 Oct 10:1-10. doi: 10.1080/14779072.2023.2266368. Online ahead of print.ABSTRACTINTRODUCTION: With the expanding indications of transcatheter aortic valve replacement (TAVR) to younger and low-risk patients, the life expectancy of patients currently undergoing TAVR will likely outlive the durability of transcatheter bioprosthesis. Consequently, the number of failed transcatheter bioprosthesis requiring surgical valve explant or redo TAVR is expected to increase.AREAS COVERED: The aim of this review is to provide an updated overview of redo TAVR for treating degenerated transcatheter bioprost...
Source: Expert Review of Cardiovascular Therapy - October 10, 2023 Category: Cardiology Authors: Juan S ánchez-Ceña Lluis Asmarats Chi Hion Pedro Li Xavier Mill án Estefan ía Fernández-Peregrina Irene Mendui ña Albert Mass ó van Roessel Dabit Arzamendi Source Type: research
Preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists
Expert Rev Cardiovasc Ther. 2023 Oct 4:1-2. doi: 10.1080/14779072.2023.2264774. Online ahead of print.NO ABSTRACTPMID:37791465 | DOI:10.1080/14779072.2023.2264774 (Source: Expert Review of Cardiovascular Therapy)
Source: Expert Review of Cardiovascular Therapy - October 4, 2023 Category: Cardiology Authors: Chia Siang Kow Dinesh Sangarran Ramachandram Syed Shahzad Hasan Source Type: research
Assisted reproductive technology: what are the cardiovascular risks for women?
Expert Rev Cardiovasc Ther. 2023 Oct 2. doi: 10.1080/14779072.2023.2266355. Online ahead of print.ABSTRACTINTRODUCTION: Infertility affects 15% of women of reproductive age in the United States. The use of assisted reproductive technology (ART) has been rising globally, as well as a growing recognition of reproductive factors that increase risk for cardiovascular disease (CVD).AREAS COVERED: Women with infertility who use ART are more likely to have established CVD risk factors, such as obesity, dyslipidemia, hypertension, and diabetes. They are also more likely to experience adverse pregnancy outcomes, which are associate...
Source: Expert Review of Cardiovascular Therapy - October 2, 2023 Category: Cardiology Authors: Carolyn Guan Carla Rodriguez Petal Elder-Odame Anum S Minhas Salman Zahid Valerie L Baker Chrisandra L Shufelt Erin D Michos Source Type: research
Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging
This article describes the advantages and disadvantages of the current diagnostic criteria for CS, and typical imaging and clinical courses.EXPERT OPINION: The diagnosis of clinical CS has been made possible by recent developments in multimodality imaging. However, it is still crucial to look for histological signs of sarcoidosis in other organs in addition to the endomyocardium. Additionally, phenotyping based on clinical manifestations such as heart failure, conduction abnormality or ventricular arrhythmia, and extracardiac abnormalities is clinically significant.PMID:37776232 | DOI:10.1080/14779072.2023.2266367 (Source:...
Source: Expert Review of Cardiovascular Therapy - September 30, 2023 Category: Cardiology Authors: Shinichi Kurashima Takeshi Kitai Andrew Xanthopoulos John Skoularigis Filippos Triposkiadis Chisato Izumi Source Type: research
Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease
Expert Rev Cardiovasc Ther. 2023 Sep 29. doi: 10.1080/14779072.2023.2264779. Online ahead of print.ABSTRACTINTRODUCTION: Coronary Artery Disease (CAD) is a prevalent condition characterized by the presence of atherosclerotic plaques in the small coronary arteries of the heart. The global burden of CAD has increased significantly over the years, resulting in millions of deaths annually and making it the leading healthcare expenditure and cause of mortality in developed countries. The lack of cost-effective strategies for monitoring the prognosis of CAD warrants a pressing need for accurate and efficient markers to assess di...
Source: Expert Review of Cardiovascular Therapy - September 29, 2023 Category: Cardiology Authors: Armand N Yazdani Michaela Pletsch Abraham Chorbajian David Zitser Vikrant Rai Devendra K Agrawal Source Type: research
